OZT: Balloon Aortic Valvuloplasty
What it covers
A balloon aortic valvuloplasty catheter is indicated for balloon valvuloplasty of the aortic valve.
FDA’s definition of product code OZT, from the Product Classification database.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K253855 | KardiaPSI Balloon Catheter | Intervention Tech, Inc. ; dba Corvention | May 6, 2026 | Traditional |
| K260437 | Valvuloplasty Balloon Catheter (ValvuloPro) | Dongguan TT Medical, Inc. | Mar 20, 2026 | Special |
| K241562 | OutFlo Aortic Valve Dilatation Balloon Catheter | Disa Medinotec | Mar 11, 2025 | Traditional |
| K240967 | ValvuloPro Valvuloplasty Balloon Catheter | Dongguan TT Medical, Inc. | Jul 31, 2024 | Special |
| K231814 | ValvuloPro Valvuloplasty Balloon Catheter | Dongguan TT Medical, Inc. | Oct 12, 2023 | Traditional |
| K220881 | INOUE BALLOON A | Toray Industries, Inc. | Dec 18, 2022 | Traditional |
| K172932 | True Flow Valvuloplasty Perfusion Catheter | C.R. Bard, Inc. | Dec 13, 2017 | Traditional |
| K152613 | True Flow Valvuloplasty Perfusion Catheter | C.R. Bard, Inc. | Jan 19, 2016 | Traditional |
| K152150 | V8 Balloon Aortic Valvuloplasty Catheter | Intervalve, Inc. | Dec 18, 2015 | Traditional |
| K150667 | True Dilatation Balloon Valvuloplasty Catheter | C.R. Bard, Inc. | Jun 17, 2015 | Traditional |
Clearances by year
22 OZT 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 2 | 96 |
| 2025 | 1 | 284 |
| 2024 | 1 | 113 |
| 2023 | 1 | 113 |
| 2022 | 1 | 268 |
| 2017 | 1 | 78 |
| 2016 | 1 | 127 |
| 2015 | 4 | 115 |
| 2014 | 4 | 79 |
| 2013 | 3 | 80 |
| 2012 | 3 | 184 |
Who submits
11 applicants cleared a OZT device since 2011. 77% of the clearances went to applicants in United States, then China (14%), Japan (5%) and South Africa (5%). By type: Traditional 73%, Special 23% and Post-NSE 5%.
| Applicant | Clearances since 2011 |
|---|---|
| C.R. Bard, Inc. | 5 |
| Intervalve, Inc. | 5 |
| Dongguan TT Medical, Inc. | 3 |
| NuMED, Inc. | 2 |
| Bard Peripheral Vascular, Inc. | 1 |
| Disa Medinotec | 1 |
| Edwards Lifesciences | 1 |
| Edwards Lifesciences, LLC | 1 |
How FDA classifies it
Class II (special controls). The special controls for this device are:
(1) The device must be demonstrated to be biocompatible.
(2) Sterility and shelf life testing must demonstrate the sterility of patient-contacting components and the shelf life of these components.
(3) Non-clinical performance evaluation must demonstrate that the device performs as intended under anticipated conditions of use, including device delivery, inflation, deflation, and removal.
(4) In vivo evaluation of the device must demonstrate device performance, including the ability of the device to treat aortic stenosis.
(5) Labeling must include a detailed summary of the device-related and procedure-related complications pertinent to the use of the device.
From 21 CFR 870.1255. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 870.1255 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent OZT clearances declared.
Ask about OZT
Questions about OZT
What is FDA product code OZT?
Product code OZT, “Balloon Aortic Valvuloplasty” in FDA's classification database, is a Class II device type under 21 CFR 870.1255 (balloon aortic valvuloplasty catheter), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 22 clearances under OZT, 22 of them since 2011.
How many 510(k) clearances are there under OZT?
FDA’s 510(k) database listed 22 clearances under OZT as of Oct 29, 2026, 22 of them decided since 2011; the most recent decision was May 6, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a OZT 510(k)?
For the 3 OZT clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 154 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most OZT clearances?
Since 2011: C.R. Bard, Inc. (5), Intervalve, Inc. (5), Dongguan TT Medical, Inc. (3), NuMED, Inc. (2) and Bard Peripheral Vascular, Inc. (1). 11 applicants have cleared a OZT device in that time.